Andrew M Borman
Overview
Explore the profile of Andrew M Borman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
2196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brown L, Tschiderer L, Alanio A, Barnes R, Chen S, Cogliati M, et al.
EClinicalMedicine
. 2025 Mar;
81:103115.
PMID: 40083443
Background: This systematic review and meta-analysis aimed to examine the performance of polymerase chain reaction (PCR) assays for diagnosing mucormycosis. Methods: A standardised search was conducted from conception to December...
2.
Abdolrasouli A, Barton R, Borman A
Emerg Infect Dis
. 2024 Dec;
31(1):192-194.
PMID: 39714510
We describe 157 cases of Trichophyton indotineae infection in the United Kingdom, mostly in patients linked to southern Asia. T. indotineae is spreading in the United Kingdom and accounts for...
3.
Balazsi D, Toth Z, Locke J, Borman A, Forgacs L, Balla N, et al.
J Fungi (Basel)
. 2024 Sep;
10(9).
PMID: 39330378
Objectives: Rezafungin is the first new drug approved to treat candidaemia and invasive candidiasis in more than 10 years. However, data are scant on the in vivo efficacy of rezafungin...
4.
Farrugia L, Baston V, Burfield L, Melly L, Borman A, Bal A
Med Mycol Case Rep
. 2024 Aug;
45:100664.
PMID: 39161845
and species are increasingly recognized as significant opportunistic fungal pathogens. We report a rare case of co-infection in a 63-year old heart transplant recipient presenting with nodular skin lesions, treated...
5.
Arendrup M, Armstrong-James D, Borman A, Denning D, Fisher M, Gorton R, et al.
Open Forum Infect Dis
. 2024 Jul;
11(7):ofae372.
PMID: 39045012
Fungal diseases represent a considerable global health concern, affecting >1 billion people annually. In response to this growing challenge, the World Health Organization introduced the pivotal fungal priority pathogens list...
6.
Teoh P, McGuire E, Borman A, Gorton R, Wilson A, Merrion C, et al.
Med Mycol Case Rep
. 2024 Jul;
45:100656.
PMID: 39026576
Invasive fungal infection is a life-threatening complication of chemotherapy and neutropaenia in the haematology population. species rarely cause human disease but have been reported to cause invasive infection in the...
7.
Brown G, Ballou E, Bates S, Bignell E, Borman A, Brand A, et al.
Nat Rev Microbiol
. 2024 Jun;
22(11):687-704.
PMID: 38918447
Human fungal infections are a historically neglected area of disease research, yet they cause more than 1.5 million deaths every year. Our understanding of the pathophysiology of these infections has...
8.
Jones C, Neill C, Borman A, Budd E, Cummins M, Fry C, et al.
J Med Microbiol
. 2024 May;
73(5).
PMID: 38771623
The emergent fungal pathogen is increasingly recognised as an important cause of healthcare-associated infections globally. It is highly transmissible, adaptable, and persistent, resulting in an organism with significant outbreak potential...
9.
Tatarinova O, Furness C, Borman A, Barber J, Muthialu N, Ferreras-Antolin L
Med Mycol Case Rep
. 2024 Apr;
44:100645.
PMID: 38617461
is a known cause of fungal infection in humans and animals. It is found to be more refractory to antifungal treatment in comparison to other species. With this report we...
10.
Spruijtenburg B, de Souza Lima B, Tosar S, Borman A, Andersen C, Nizamuddin S, et al.
Infection
. 2024 Apr;
52(5):1799-1812.
PMID: 38573472
Purpose: Rare yeasts species are increasingly reported as causative agents of invasive human infection. Proper identification and antifungal therapy are essential to manage these infections. Candida blankii is one of...